These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 17524240)

  • 1. Differential involvement of TRPV1 receptors at the central and peripheral nerves in CFA-induced mechanical and thermal hyperalgesia.
    Kanai Y; Hara T; Imai A; Sakakibara A
    J Pharm Pharmacol; 2007 May; 59(5):733-8. PubMed ID: 17524240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-(4-Tertiarybutylphenyl)-4-(3-cholorphyridin-2-yl)tetrahydropyrazine -1(2H)-carbox-amide (BCTC), a novel, orally effective vanilloid receptor 1 antagonist with analgesic properties: II. in vivo characterization in rat models of inflammatory and neuropathic pain.
    Pomonis JD; Harrison JE; Mark L; Bristol DR; Valenzano KJ; Walker K
    J Pharmacol Exp Ther; 2003 Jul; 306(1):387-93. PubMed ID: 12721336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of an increased spinal TRPV1 sensitization through its up-regulation in mechanical allodynia of CCI rats.
    Kanai Y; Nakazato E; Fujiuchi A; Hara T; Imai A
    Neuropharmacology; 2005 Dec; 49(7):977-84. PubMed ID: 15998524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic and site-specific effects of A-425619, a selective TRPV1 receptor antagonist, on wide dynamic range neurons in CFA-treated and uninjured rats.
    McGaraughty S; Chu KL; Faltynek CR; Jarvis MF
    J Neurophysiol; 2006 Jan; 95(1):18-25. PubMed ID: 16162831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TRPV1 receptor signaling mediates afferent nerve sensitization during colitis-induced motility disorders in rats.
    De Schepper HU; De Man JG; Ruyssers NE; Deiteren A; Van Nassauw L; Timmermans JP; Martinet W; Herman AG; Pelckmans PA; De Winter BY
    Am J Physiol Gastrointest Liver Physiol; 2008 Jan; 294(1):G245-53. PubMed ID: 17991707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RNA interference-mediated knock-down of transient receptor potential vanilloid 1 prevents forepaw inflammatory hyperalgesia in rat.
    Kasama S; Kawakubo M; Suzuki T; Nishizawa T; Ishida A; Nakayama J
    Eur J Neurosci; 2007 May; 25(10):2956-63. PubMed ID: 17509082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of novel 6,6-heterocycles as transient receptor potential vanilloid (TRPV1) antagonists.
    Blum CA; Caldwell T; Zheng X; Bakthavatchalam R; Capitosti S; Brielmann H; De Lombaert S; Kershaw MT; Matson D; Krause JE; Cortright D; Crandall M; Martin WJ; Murphy BA; Boyce S; Jones AB; Mason G; Rycroft W; Perrett H; Conley R; Burnaby-Davies N; Chenard BL; Hodgetts KJ
    J Med Chem; 2010 Apr; 53(8):3330-48. PubMed ID: 20307063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antihyperalgesic effects of (R,E)-N-(2-hydroxy-2,3-dihydro-1H-inden-4-yl)-3-(2-(piperidin-1-yl)-4-(trifluoromethyl)phenyl)-acrylamide (AMG8562), a novel transient receptor potential vanilloid type 1 modulator that does not cause hyperthermia in rats.
    Lehto SG; Tamir R; Deng H; Klionsky L; Kuang R; Le A; Lee D; Louis JC; Magal E; Manning BH; Rubino J; Surapaneni S; Tamayo N; Wang T; Wang J; Wang J; Wang W; Youngblood B; Zhang M; Zhu D; Norman MH; Gavva NR
    J Pharmacol Exp Ther; 2008 Jul; 326(1):218-29. PubMed ID: 18420600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A distinct role for transient receptor potential ankyrin 1, in addition to transient receptor potential vanilloid 1, in tumor necrosis factor α-induced inflammatory hyperalgesia and Freund's complete adjuvant-induced monarthritis.
    Fernandes ES; Russell FA; Spina D; McDougall JJ; Graepel R; Gentry C; Staniland AA; Mountford DM; Keeble JE; Malcangio M; Bevan S; Brain SD
    Arthritis Rheum; 2011 Mar; 63(3):819-29. PubMed ID: 21360511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of peripheral vanilloid TRPV1 receptors reduces noxious heat-evoked responses of dorsal horn neurons in naïve, carrageenan-inflamed and neuropathic rats.
    Jhaveri MD; Elmes SJ; Kendall DA; Chapman V
    Eur J Neurosci; 2005 Jul; 22(2):361-70. PubMed ID: 16045489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TRPV1 antagonist, SB-366791, inhibits glutamatergic synaptic transmission in rat spinal dorsal horn following peripheral inflammation.
    Lappin SC; Randall AD; Gunthorpe MJ; Morisset V
    Eur J Pharmacol; 2006 Jul; 540(1-3):73-81. PubMed ID: 16737693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contributions of central and peripheral TRPV1 receptors to mechanically evoked and spontaneous firing of spinal neurons in inflamed rats.
    McGaraughty S; Chu KL; Brown BS; Zhu CZ; Zhong C; Joshi SK; Honore P; Faltynek CR; Jarvis MF
    J Neurophysiol; 2008 Dec; 100(6):3158-66. PubMed ID: 18829846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design of potent, orally available antagonists of the transient receptor potential vanilloid 1. Structure-activity relationships of 2-piperazin-1-yl-1H-benzimidazoles.
    Ognyanov VI; Balan C; Bannon AW; Bo Y; Dominguez C; Fotsch C; Gore VK; Klionsky L; Ma VV; Qian YX; Tamir R; Wang X; Xi N; Xu S; Zhu D; Gavva NR; Treanor JJ; Norman MH
    J Med Chem; 2006 Jun; 49(12):3719-42. PubMed ID: 16759115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mu-opioid receptor activation modulates transient receptor potential vanilloid 1 (TRPV1) currents in sensory neurons in a model of inflammatory pain.
    Endres-Becker J; Heppenstall PA; Mousa SA; Labuz D; Oksche A; Schäfer M; Stein C; Zöllner C
    Mol Pharmacol; 2007 Jan; 71(1):12-8. PubMed ID: 17005903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TRPV1 desensitisation and endogenous vanilloid involvement in the enhanced analgesia induced by capsaicin in inflamed tissues.
    Baamonde A; Lastra A; Juarez L; Hidalgo A; Menéndez L
    Brain Res Bull; 2005 Nov; 67(6):476-81. PubMed ID: 16216696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transient receptor potential vanilloid 1 mediates hyperalgesia and is up-regulated in rats with chronic pancreatitis.
    Xu GY; Winston JH; Shenoy M; Yin H; Pendyala S; Pasricha PJ
    Gastroenterology; 2007 Oct; 133(4):1282-92. PubMed ID: 17698068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TRPV1 receptors in the CNS play a key role in broad-spectrum analgesia of TRPV1 antagonists.
    Cui M; Honore P; Zhong C; Gauvin D; Mikusa J; Hernandez G; Chandran P; Gomtsyan A; Brown B; Bayburt EK; Marsh K; Bianchi B; McDonald H; Niforatos W; Neelands TR; Moreland RB; Decker MW; Lee CH; Sullivan JP; Faltynek CR
    J Neurosci; 2006 Sep; 26(37):9385-93. PubMed ID: 16971522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proton activation does not alter antagonist interaction with the capsaicin-binding pocket of TRPV1.
    Gavva NR; Tamir R; Klionsky L; Norman MH; Louis JC; Wild KD; Treanor JJ
    Mol Pharmacol; 2005 Dec; 68(6):1524-33. PubMed ID: 16135784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of transient receptor potential vanilloid 1 receptors in protease-activated receptor-2-induced joint inflammation and nociception.
    Helyes Z; Sándor K; Borbély E; Tékus V; Pintér E; Elekes K; Tóth DM; Szolcsányi J; McDougall JJ
    Eur J Pain; 2010 Apr; 14(4):351-8. PubMed ID: 19683949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A-425619 [1-isoquinolin-5-yl-3-(4-trifluoromethyl-benzyl)-urea], a novel transient receptor potential type V1 receptor antagonist, relieves pathophysiological pain associated with inflammation and tissue injury in rats.
    Honore P; Wismer CT; Mikusa J; Zhu CZ; Zhong C; Gauvin DM; Gomtsyan A; El Kouhen R; Lee CH; Marsh K; Sullivan JP; Faltynek CR; Jarvis MF
    J Pharmacol Exp Ther; 2005 Jul; 314(1):410-21. PubMed ID: 15837818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.